Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.
Department of Ophthalmology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Cornea. 2023 Feb 1;42(2):150-155. doi: 10.1097/ICO.0000000000003001. Epub 2022 Feb 4.
The purpose of this study was to evaluate long-term corneal endothelial cell changes and visual outcomes after iris-fixated phakic intraocular lens (pIOL) explantation in patients with endothelial damage and to investigate potential predictors of endothelial injury.
Consecutive patients undergoing pIOL explantation with corneal endothelial cell density (ECD) <2000 cells/mm 2 at the time of the procedure were retrospectively reviewed in a single tertiary center. All patients were treated between April 2016 and October 2020 at a high-volume referral-based tertiary hospital. The primary outcome was the change in corneal endothelial parameters, including ECD, over long-term follow-up. Secondary outcomes included changes in corrected distance visual acuity and analysis of prognostic factors.
This study included 44 eyes from 28 patients with an average age of 42.5 ± 7.8 years (range: 27-63). Mean ECD before explantation was 1375.4 ± 468.2 cells/mm 2 (range: 622-1996), and the average duration of follow-up after explantation was 20.5 months (6-58.2). Two years after explantation, ECD had significantly decreased by more than 25% to 1019.6 ± 368.6 (608-1689; P < 0.01). However, there was no significant change in corrected distance visual acuity (20/23-20/22, P = 0.59). Longer operation duration (odds ratio, 1.004; P = 0.04) was the only significant factor weakly associated with postoperative decreases in ECD.
Although ECD continuously decreased despite pIOL explantation on a long-term follow-up, patients did not experience any discomfort or showed decreases in visual acuity. Therefore, a careful follow-up is required for possible endothelial injury after pIOL explantation.
本研究旨在评估内皮损伤患者行虹膜固定型有晶状体眼人工晶状体(pIOL)取出术后的长期角膜内皮细胞变化和视力结果,并探讨内皮损伤的潜在预测因素。
回顾性分析 2016 年 4 月至 2020 年 10 月在一家高容量的基于转诊的三级医院行 pIOL 取出术且术前角膜内皮细胞密度(ECD)<2000 个细胞/mm 2 的连续患者。所有患者均在该中心接受治疗。本研究的主要结局是长期随访中角膜内皮参数(包括 ECD)的变化。次要结局包括矫正视力和分析预后因素的变化。
本研究共纳入 28 例 44 只眼患者,平均年龄 42.5 ± 7.8 岁(范围:27-63)。pIOL 取出术前 ECD 平均值为 1375.4 ± 468.2 个细胞/mm 2 (范围:622-1996),pIOL 取出后平均随访时间为 20.5 个月(6-58.2)。pIOL 取出 2 年后,ECD 显著下降超过 25%,至 1019.6 ± 368.6 个细胞/mm 2 (608-1689;P < 0.01)。然而,矫正视力无显著变化(20/23-20/22,P = 0.59)。较长的手术时间(优势比,1.004;P = 0.04)是与术后 ECD 下降唯一相关的显著因素。
尽管在长期随访中尽管行 pIOL 取出术,但 ECD 仍持续下降,患者未出现任何不适或视力下降。因此,pIOL 取出后需要对可能的内皮损伤进行密切随访。